These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 37907864)
1. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity. Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864 [TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y Front Immunol; 2023; 14():1128390. PubMed ID: 36761753 [TBL] [Abstract][Full Text] [Related]
4. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma. Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761 [TBL] [Abstract][Full Text] [Related]
5. Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy. Xia M; Wang S; Ye Y; Tu Y; Huang T; Gao L Front Immunol; 2022; 13():995645. PubMed ID: 36389678 [TBL] [Abstract][Full Text] [Related]
6. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets. Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y Front Immunol; 2022; 13():964891. PubMed ID: 36059514 [TBL] [Abstract][Full Text] [Related]
7. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer. Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990 [TBL] [Abstract][Full Text] [Related]
8. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma. Dong W; Du D; Huang H Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163 [TBL] [Abstract][Full Text] [Related]
9. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells. Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150 [TBL] [Abstract][Full Text] [Related]
10. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model. Fei H; Han X; Wang Y; Li S Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551 [TBL] [Abstract][Full Text] [Related]
11. Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer. Guo L; Yuan M; Jiang S; Jin G; Li P Transl Cancer Res; 2023 Dec; 12(12):3360-3383. PubMed ID: 38193001 [TBL] [Abstract][Full Text] [Related]
12. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer. Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma. Zhang X; Meng X; Wang P; Luan C; Wang H Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263 [TBL] [Abstract][Full Text] [Related]
15. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning. Liu Y; Yin Z; Wang Y; Chen H Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565 [TBL] [Abstract][Full Text] [Related]
16. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment. Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507 [TBL] [Abstract][Full Text] [Related]
17. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer. Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma. Wu M; Yuan H; Li X; Liao Q; Liu Z Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141 [No Abstract] [Full Text] [Related]
19. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322 [TBL] [Abstract][Full Text] [Related]
20. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]